Current approach to iron chelation in children

Area of Science:

• Pediatric Hematology
• Iron Metabolism Disorders
• Pharmacology

Background:

• Children with transfusion-dependent conditions like thalassaemia major and inherited bone marrow failure syndromes are at risk of severe iron overload.
• Ineffective erythropoiesis in conditions such as non-transfusion-dependent thalassaemia (NTDT) can also cause iron overload due to increased gut iron absorption from childhood.

Purpose of the Study:

• To shift the goal of iron chelation therapy from treating existing overload to preventing iron accumulation and end-organ damage.
• To achieve complication-free survival and enhance the quality of life for children with iron overload conditions.
• To explore the role of new chelation options in pediatric iron overload management.

Main Methods:

• Review of current clinical practices and therapeutic goals in pediatric iron chelation.
• Analysis of the impact of new chelation agents on preventing iron accumulation.
• Discussion of optimal monitoring and adjustment strategies for chelation therapy in children.

Main Results:

• Newer iron chelation options offer improved prospects for preventing iron overload complications.
• Optimal chelation therapy in children requires timely initiation, close monitoring, and continuous adjustment.
• Pediatric patients have higher transfusional requirements, necessitating tailored chelation approaches for adequate growth and development.

Conclusions:

• Iron chelation therapy in children aims to prevent iron accumulation and associated end-organ damage for improved long-term outcomes.
• Despite advancements, uncertainties remain regarding the optimal initiation levels and depletion targets for iron chelation in pediatric populations.
• Effective management of iron overload in children is crucial for achieving normal growth, development, and a high quality of life.